Neovacs
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
ALNEV | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0004032746 (+4 more)
- LEI:
- 9695001J9GMM5XYK6482
- Country:
- France
- Address:
- 14 RUE DE LA REPUBLIQUE, 92150 SURESNES
- Website:
- https://www.neovacs.com/en/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Neovacs is a biotechnology company with a dual business model focused on research and development (R&D) and strategic investment. The company's R&D centers on its proprietary Kinoid technology platform, an active immunotherapy approach for developing therapeutic vaccines. This technology is designed to treat autoimmune diseases and allergies, such as lupus, by stimulating the patient's immune system to regulate the overproduction of harmful cytokines. In parallel with its internal product development, Neovacs leverages its team's expertise to invest in high-potential biotechnology (BioTech) and medical device (MedTech) companies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-23 19:00 |
Capital/Financing Update
Nouveau contrat de financement d'un montant nominal maximal de 10 MEUR sur une …
|
French | 372.7 KB | ||
| 2025-07-08 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 273.5 KB | ||
| 2025-06-03 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 252.7 KB | ||
| 2025-06-02 08:00 |
Share Issue/Capital Change
Regroupement des actions Néovacs et suspension de la faculté d'exercice des val…
|
French | 230.9 KB | ||
| 2025-05-27 21:00 |
Share Issue/Capital Change
Levée de fonds de 0,5 MEUR
|
French | 231.6 KB | ||
| 2025-05-16 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 230.1 KB | ||
| 2025-05-06 20:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 213.4 KB | ||
| 2025-05-06 08:00 |
Earnings Release
Résultats annuels 2024
|
French | 255.3 KB | ||
| 2025-05-05 12:00 |
Share Issue/Capital Change
Levée de fonds de 1,2 MEUR
|
French | 231.2 KB | ||
| 2025-04-30 18:00 |
Capital/Financing Update
Levée de fonds de 0,25 MEUR
|
French | 234.1 KB | ||
| 2025-04-17 18:30 |
Share Issue/Capital Change
Levée de fonds de 0,25 M EUR
|
French | 248.3 KB | ||
| 2025-04-16 08:00 |
Legal Proceedings Report
Néovacs fait le point sur des rumeurs
|
French | 235.6 KB | ||
| 2025-04-02 20:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 210.1 KB | ||
| 2025-03-28 08:00 |
Regulatory News Service
Néovacs co-organise la 1ère rencontre Française sur les Nanoparticules Lipidiqu…
|
French | 225.9 KB | ||
| 2025-03-25 08:00 |
Capital/Financing Update
Signature d'un avenant à la convention de fiducie
|
French | 238.6 KB |
Automate Your Workflow. Get a real-time feed of all Neovacs filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Neovacs via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
